Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,478 | 86 | 99.1% |
| Education | $12.70 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $270.57 | 21 | $0 (2019) |
| GlaxoSmithKline, LLC. | $248.83 | 16 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $243.69 | 18 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $156.76 | 5 | $0 (2018) |
| Genentech USA, Inc. | $120.41 | 8 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $118.26 | 2 | $0 (2023) |
| Mylan Specialty L.P. | $53.14 | 3 | $0 (2024) |
| KARL STORZ Endoscopy-America | $49.93 | 1 | $0 (2017) |
| GENZYME CORPORATION | $40.25 | 1 | $0 (2024) |
| PFIZER INC. | $37.93 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.46 | 3 | GENZYME CORPORATION ($40.25) |
| 2023 | $118.26 | 2 | Regeneron Healthcare Solutions, Inc. ($118.26) |
| 2020 | $157.89 | 13 | Actelion Pharmaceuticals US, Inc. ($157.89) |
| 2019 | $286.62 | 19 | Actelion Pharmaceuticals US, Inc. ($85.80) |
| 2018 | $323.73 | 20 | Sunovion Pharmaceuticals Inc. ($146.46) |
| 2017 | $518.09 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($135.84) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/30/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: PULMONOLOGY | ||||||
| 01/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.25 | General |
| Category: Immunology | ||||||
| 12/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $88.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/27/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiology | ||||||
| 08/06/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology | ||||||
| 07/10/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiology | ||||||
| 06/05/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology | ||||||
| 05/08/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiology | ||||||
| 04/22/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Cardiology | ||||||
| 03/02/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiology | ||||||
| 01/30/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiology | ||||||
| 01/28/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Cardiology | ||||||
| 01/23/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Cardiology | ||||||
| 01/07/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Cardiology | ||||||
| 01/06/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: Cardiology | ||||||
| 01/06/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Cardiology | ||||||
| 12/20/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology | ||||||
| 11/22/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory and Allergy | ||||||
| 11/21/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology | ||||||
| 11/14/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiology | ||||||
| 11/07/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 90 | 191 | $98,675 | $24,918 |
| 2022 | 2 | 56 | 92 | $50,524 | $12,543 |
| 2021 | 3 | 137 | 230 | $112,489 | $29,278 |
| 2020 | 10 | 456 | 849 | $386,027 | $109,399 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 52 | 116 | $78,068 | $18,851 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 42 | $13,314 | $3,981 | 29.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 33 | $7,293 | $2,085 | 28.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 38 | 60 | $40,380 | $9,996 | 24.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 32 | $10,144 | $2,546 | 25.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 75 | 121 | $78,871 | $20,487 | 26.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 94 | $28,713 | $7,482 | 26.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 14 | 15 | $4,905 | $1,309 | 26.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 171 | 411 | $255,821 | $73,058 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 125 | 227 | $65,929 | $18,958 | 28.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 39 | 66 | $20,262 | $5,841 | 28.8% |
| 31600 | Opening of windpipe through neck for insertion of breathing tube | Facility | 2020 | 13 | 13 | $14,300 | $3,255 | 22.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $10,602 | $3,147 | 29.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 52 | $10,296 | $3,061 | 29.7% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 12 | 12 | $4,080 | $840.12 | 20.6% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 15 | 15 | $2,145 | $513.08 | 23.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 14 | 16 | $1,728 | $512.25 | 29.6% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2020 | 14 | 18 | $864.00 | $213.48 | 24.7% |
About Dr. Koonj Shah, MD
Dr. Koonj Shah, MD is a Critical Care Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316193907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Koonj Shah, MD has received a total of $1,491 in payments from pharmaceutical and medical device companies, with $86.46 received in 2024. These payments were reported across 87 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,478).
As a Medicare-enrolled provider, Shah has provided services to 739 Medicare beneficiaries, totaling 1,362 services with total Medicare billing of $176,137. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Location Austin, TX
- Active Since 08/14/2008
- Last Updated 06/14/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1316193907
Products in Payments
- UPTRAVI (Drug) $243.69
- NUCALA (Biological) $176.99
- DUPIXENT (Biological) $158.51
- LONHALA MAGNAIR (Drug) $132.59
- Esbriet (Biological) $120.41
- Utibron (Drug) $81.23
- ANORO (Drug) $71.84
- 7 FLAT PANEL MONITOR ONLY F/C-MAC, HDMI (Device) $49.93
- UTIBRON (Drug) $40.26
- OFEV (Drug) $33.44
- AVYCAZ (Drug) $31.63
- Yupelri (Drug) $30.86
- SMARTVEST (Device) $29.15
- Prolastin-C Liquid (Biological) $25.96
- CHANTIX (Drug) $25.13
- CHARTIS CATHETER (Device) $23.93
- YUPELRI (Drug) $22.28
- SPIRIVA RESPIMAT (Drug) $20.92
- SYMBICORT (Drug) $17.32
- BROVANA (Drug) $16.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Austin
Shenil Shah, M.d, M.D
Critical Care Medicine — Payments: $5,658
Mr. Christopher Brown, M.d, M.D
Critical Care Medicine — Payments: $3,132
Robert Morrison, M.d, M.D
Critical Care Medicine — Payments: $2,860
Dr. Thaw Sint, Md, MD
Critical Care Medicine — Payments: $2,422
Dr. Anna Dvorak, Md, MD
Critical Care Medicine — Payments: $2,311
Andrea Fekete, M.d, M.D
Critical Care Medicine — Payments: $2,237